Katie L Burkhouse1, Autumn Kujawa1, Heide Klumpp1,2, Kate D Fitzgerald3, Christopher S Monk3,4, K Luan Phan1,2,5. 1. Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA. 2. Department of Psychology, University of Illinois at Chicago, Chicago, IL, USA. 3. Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA. 4. Department of Psychology, University of Michigan, Ann Arbor, MI, USA. 5. Department of Anatomy and Cell Biology, and Graduate Program in Neuroscience, University of Illinois at Chicago, Chicago, IL, USA.
Abstract
BACKGROUND: Approximately 40%-45% of youth with anxiety disorders do not achieve remission (or a substantial reduction in symptoms) following treatment, highlighting the need to identify predictors of treatment response. Given the well-established link between attentional biases and anxiety disorders in youth and adults, this study examined the neural correlates of directing attention toward and away from emotional faces in relation to pediatric anxiety treatment response. METHOD: Prior to beginning treatment with the selective serotonin reuptake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), 37 youth (age 7-19 years) with generalized and/or social anxiety disorder completed a task with conditions that manipulated whether participants were instructed to match emotional faces (explicit emotion processing) or match shapes in the context of emotional face distractors (implicit emotion processing) during functional magnetic resonance imaging. RESULTS: Results revealed that reduced activation in superior frontal gyrus (SFG), encompassing the dorsal anterior cingulate cortex (ACC) and dorsomedial prefrontal cortex (PFC), during implicit processing of emotional faces predicted a greater reduction in anxiety severity pre-to-post treatment. Post hoc analyses indicated that effects were not significantly moderated by the type of treatment or anxiety type. CONCLUSIONS: Findings suggest that less recruitment of SFG, including the dorsal ACC and dorsomedial PFC, during implicit emotion processing predicts a greater reduction in youth anxiety symptoms pre-to-post treatment. Youth who exhibit reduced activation in these areas while matching shapes in the context of emotional face distractors may have more to gain from CBT and SSRI treatment due to preexisting deficits in attentional control. These findings suggest that neuroimaging may be a useful tool for predicting which youth are most likely to benefit from anxiety treatment.
BACKGROUND: Approximately 40%-45% of youth with anxiety disorders do not achieve remission (or a substantial reduction in symptoms) following treatment, highlighting the need to identify predictors of treatment response. Given the well-established link between attentional biases and anxiety disorders in youth and adults, this study examined the neural correlates of directing attention toward and away from emotional faces in relation to pediatric anxiety treatment response. METHOD: Prior to beginning treatment with the selective serotonin reuptake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), 37 youth (age 7-19 years) with generalized and/or social anxiety disorder completed a task with conditions that manipulated whether participants were instructed to match emotional faces (explicit emotion processing) or match shapes in the context of emotional face distractors (implicit emotion processing) during functional magnetic resonance imaging. RESULTS: Results revealed that reduced activation in superior frontal gyrus (SFG), encompassing the dorsal anterior cingulate cortex (ACC) and dorsomedial prefrontal cortex (PFC), during implicit processing of emotional faces predicted a greater reduction in anxiety severity pre-to-post treatment. Post hoc analyses indicated that effects were not significantly moderated by the type of treatment or anxiety type. CONCLUSIONS: Findings suggest that less recruitment of SFG, including the dorsal ACC and dorsomedial PFC, during implicit emotion processing predicts a greater reduction in youth anxiety symptoms pre-to-post treatment. Youth who exhibit reduced activation in these areas while matching shapes in the context of emotional face distractors may have more to gain from CBT and SSRI treatment due to preexisting deficits in attentional control. These findings suggest that neuroimaging may be a useful tool for predicting which youth are most likely to benefit from anxiety treatment.
Authors: Erin B McClure; Abby Adler; Christopher S Monk; Jennifer Cameron; Samantha Smith; Eric E Nelson; Ellen Leibenluft; Monique Ernst; Daniel S Pine Journal: Psychopharmacology (Berl) Date: 2006-09-14 Impact factor: 4.530
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Johnna R Swartz; K Luan Phan; Mike Angstadt; Heide Klumpp; Kate D Fitzgerald; Christopher S Monk Journal: Depress Anxiety Date: 2014-07-03 Impact factor: 6.505
Authors: Katja Beesdo; Jennifer Y F Lau; Amanda E Guyer; Erin B McClure-Tone; Christopher S Monk; Eric E Nelson; Stephen J Fromm; Michelle A Goldwin; Hans-Ulrich Wittchen; Ellen Leibenluft; Monique Ernst; Daniel S Pine Journal: Arch Gen Psychiatry Date: 2009-03
Authors: Scott N Compton; John T Walkup; Anne Marie Albano; John C Piacentini; Boris Birmaher; Joel T Sherrill; Golda S Ginsburg; Moira A Rynn; James T McCracken; Bruce D Waslick; Satish Iyengar; Phillip C Kendall; John S March Journal: Child Adolesc Psychiatry Ment Health Date: 2010-01-05 Impact factor: 3.033
Authors: Autumn Kujawa; Katie L Burkhouse; Shannon R Karich; Kate D Fitzgerald; Christopher S Monk; K Luan Phan Journal: J Child Adolesc Psychopharmacol Date: 2019-05-07 Impact factor: 2.576
Authors: Katie L Burkhouse; Autumn Kujawa; Bobby Hosseini; Heide Klumpp; Kate D Fitzgerald; Scott A Langenecker; Christopher S Monk; K Luan Phan Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2018-03-10 Impact factor: 5.067
Authors: W Thomas Baumel; Jeffrey A Mills; Heidi K Schroeder; Ashley M Specht; Richard Rothenberg; Tara S Peris; Jeffrey R Strawn Journal: J Child Adolesc Psychopharmacol Date: 2022-05-09 Impact factor: 3.031
Authors: Amy T Peters; Katie L Burkhouse; Autumn Kujawa; Kaveh Afshar; Kate D Fitzgerald; Christopher S Monk; Greg Hajcak; K Luan Phan Journal: Dev Psychobiol Date: 2018-07-24 Impact factor: 3.038
Authors: Lu Lu; Hailong Li; William T Baumel; Jeffrey A Mills; Kim M Cecil; Heidi K Schroeder; Sarah A Mossman; Xiaoqi Huang; Qiyong Gong; John A Sweeney; Jeffrey R Strawn Journal: Neuropsychopharmacology Date: 2021-09-27 Impact factor: 8.294
Authors: Lu Lu; Jeffrey A Mills; Hailong Li; Heidi K Schroeder; Sarah A Mossman; Sara T Varney; Kim M Cecil; Xiaoqi Huang; Qiyong Gong; Laura B Ramsey; Melissa P DelBello; John A Sweeney; Jeffrey R Strawn Journal: J Am Acad Child Adolesc Psychiatry Date: 2021-02-04 Impact factor: 13.113